Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor — The Bronx, New York

Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor is a clinical research site located in The Bronx, New York, United States 10467.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Infections.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor?

Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor conducted?

Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor has 1 clinical trials on record. Their work covers Meningococcal Infections.

Is Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor accredited by Crixeo Health?

Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 77 - Montefiore Medical Center 111 East 210th Street Rosenthall Building; 4th Floor?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.